Vince Coppola Appointed to IPG Board of Directors

8/7/16

ATLANTA--(BUSINESS WIRE)--The Board of Directors of IPG yesterday announced the election of Vince Coppola to their Board. Mr. Coppola joined the company in March of this year and currently serves as the President and CEO.

“We are extremely pleased to welcome Vince to the Board,” said Dennis Antinori, Chairman of the Board for IPG. “In the relatively short time Vince has been with the organization, he has made a significant impact, and that coupled with his strategic vision for the Company makes him a valuable asset to the group. We look forward to his contributions not only as President and CEO, but as an integral member of the Board.”

Prior to IPG Mr. Coppola served as President and CEO, and board member of Triad, a surgical and pain management company. After leading the company to significant growth and profitability, Coppola stayed on as CEO with the company after the acquisition by MedSolutions in 2013 to assist in a successful integration and its continued growth. Mr. Coppola’s previous experience includes serving in Executive leadership positions with Blue Shield of California, United Health Group, Cigna, JPMorgan, and General Electric.

“I am honored to be expanding my role at IPG and joining the Board,” said Vince Coppola, President and CEO with IPG. “We have a significant opportunity to further expand our leadership position in the Device Benefit Management market and I look forward to leading the company into that next level of success.”

About IPG

IPG is the leading provider of Device Benefit Management solutions, working with the top health plans and their provider partners across the country to improve quality and reduce costs for surgical procedures through optimization of the most effective site of care and device selection, resulting in more affordable high-quality care to consumers. For more information about IPG, call us at 866.753.0046, or visit us on the web at www.ipg.com.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.